/
/
/
Changes to the FCA’s Appointed Representative Regime

Changes to the FCA’s Appointed Representative Regime

On the 8th December 2022, the Financial Conduct Authority (“FCA”) made changes to Chapter 12 of the Supervision Manual (SUP 12) of the FCA Handbook, which is concerned with the appointed representative (“AR”) regime.

The appointed representative regime allows ARs to engage in regulated activities without having to be FCA authorised. The FCA notes in PS22/11 that whilst the regime has benefits, they are infact seeing a wide range of harm across a multitude of sectors where AR’s are appointed. This is due to the fact that their principals are failing to undertake the necessary due diligence before their appointment, or once their role has begun, their principals are failing to provide an adequate level of oversight and/or control.

Consequently, further compliance requirements have been implemented on principals to ensure:

  • additional and more timely information of the AR’s is provided to the FCA, including the process in which the AR’s are overseen (Chapter 3, SUP 12); and

  • they adhere to the strengthened principal responsibilities and expectations (Chapter 4, SUP 12).

It is important for businesses to ensure these changes have been implemented within their policies and procedures, and that AR agreements have been reviewed to ensure that these enhanced compliance requirements can be met. The FCA has confirmed that they will be sending principal firms a section 165 request which requires them to provide information about their AR’s, the nature of their regulated business, anticipated revenue etc. This should have been received by principals between 08th –12th December 2022, and the deadline for completion is the 28th February 2023.

For further information concerning the changes to the AR regime, questions on how this will affect your business or to discuss the issues raised within this update, please contact our regulatory team on 01276 686 222 or mark.chapman@herrington-carmichael.com.

Authors

Mark Chapman PNG
Mark Chapman
General Counsel, Head of Commercial & Regulatory
01276 854 928
mark.chapman@hc.law

Want to read more?

Explore our latest insights.

Related posts

Businessman checking negative customer reviews and low ratings, analyzing dissatisfied users, service review surveys, online reputation management, and business improvement strategy.

Data Protection Complaints: New Legal Requirements from June 2026

All organisations acting as data controllers will be required to operate a formal internal process for handling data protection complaints,…
3 months ago
Beautiful young woman scientist in laboratory working. Young fem

Patience is a Virtue – the State of Life Sciences Capital Transactions in the UK

Life sciences investment transactions have shown a clear trend over the last few years – fewer transactions, but for higher…
5 months ago
Doctor using tablet for patient data entry - digital healthcare innovation in medical technology

The Unique Challenges of Selling a Medical Devices Business

Selling a business which produces or distributes equipment or devices used for medical purposes presents a unique set of challenges…
9 months ago